Products
Gadobenic acid is commercially available as a solution for injection (MultiHance). It has been approved in many countries since 2003.
Structure and properties
Gadobenic acid is present in the drug as gadobenate dimeglumine (C36H62GdN5O21, Mr = 1058.1 g/mol) is present. It is a chelate complex of the organic acid BOPTA with the gadolinium ion (Gd3+).
Effects
Gadobenic acid (ATC V08CA08) has paramagnetic properties. It allows contrast enhancement in magnetic resonance imaging.
Indications
As a contrast agent for MRI diagnostics.
Dosage
According to the SmPC. The drug is administered intravenously.
Contraindications
Gadobenic acid is contraindicated in case of hypersensitivity. Full precautions can be found in the drug label.
Interactions
No information on drug-drug interactions is available.
Adverse effects
The most common possible adverse effects include headache, nausea, and injection site reactions.
